EUVIMEDEUVIMED entdecken
Crossref

Knockdown of TRIM22 regulates the expression of NF-κB/NLRP3 and alleviates inflammation and renal injury in mice with lupus nephritis

Jie Chen, Lu Liu, Min Liu, Mingming Qin, Suyan Yan, Chunfeng Wu, Wenjie Yu

Allergologia et Immunopathologia · 2025

DOI: 10.15586/aei.v53i3.1313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergologia et Immunopathologia, 2025. Verfasst von Jie Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Wuhan Third Hospital, Wuhan City, Hubei Province, China. Hauptthemen laut MEDLINE: Lupus Nephritis, NLR Family, Pyrin Domain-Containing 3 Protein, NF-kappa B, Kidney. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lupus nephritis (LN) is a common and clinically challenging complication of the systemic lupus erythematosus (SLE), but effective treatments remain imperative. Tripartite Motif Containing 22 (TRIM22) is a protein involved in various cellular processes, such as cell growth and inflammatory responses. However, the role and mechanism of TRIM22 in LN are still unclear. The aim of this study was to reveal the role of TRIM22 in LN and uncover the potential mechanisms. We discovered that TRIM22 is notably upregulated in renal tissues from patients with LN. Functionally, the knockdown of TRIM22 in lupus-prone MRL/lpr mice results in significant alleviation of LN symptoms, characterized by reduced proteinuria and improved renal function, as indicated by the lower serum levels of blood urea nitrogen and creatinine. Additionally, the intervention markedly decreases the deposition of immune complexes in the kidneys, further supporting the therapeutic potential of targeting TRIM22. Mechanically, the depletion of TRIM22 inhibits the NF-κB/NLRP3 pathway in mice with LN, but collectively, the knockdown of TRIM22 alleviates inflammation and renal injury in mice with LN via the NF-κB/NLRP3 axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisNLR Family, Pyrin Domain-Containing 3 ProteinNF-kappa BKidneyMinor Histocompatibility AntigensRepressor ProteinsAnimalsMiceHumansMice, Inbred MRL lprFemaleGene Knockdown TechniquesDisease Models, AnimalInflammationTripartite Motif ProteinsSignal Transduction

Stichwörter der Autor:innen

NF-κB/NLRP3 axisTRIM22inflammationlupus nephritis (LN)renal injury

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinNF-kappa BTRIM22 protein, humanTripartite Motif ProteinsMinor Histocompatibility AntigensRepressor ProteinsNlrp3 protein, mouse

Autor:innen und Institutionen

  • Department of Nephrology, Wuhan Third Hospital, Wuhan City, Hubei Province, China.
  • Clinical Pediatrics, Wuhan Third Hospital, Wuhan City, Hubei Province, China.
  • Department of Nephrology, Wuhan Asia General Hospital, Wuhan City, Hubei Province, China; lm_dr12@163.com.
  • Department of Nephrology, Anhui Second People's Hospital, Hefei City, Anhui Province, China.
  • Department of Internal Medicine, Wuhan Third Hospital, Wuhan City, Hubei Province, China.
  • Department of Urology, Guangdong Sunde Xinrongqi Hospital, Foshan City, Guangdong Province, China.

Zitieren

APA

Chen, J., Liu, L., Liu, M., Qin, M., Yan, S., Wu, C., & Yu, W. (2025). Knockdown of TRIM22 regulates the expression of NF-κB/NLRP3 and alleviates inflammation and renal injury in mice with lupus nephritis. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v53i3.1313

Vancouver

Chen J, Liu L, Liu M, Qin M, Yan S, Wu C, et al. Knockdown of TRIM22 regulates the expression of NF-κB/NLRP3 and alleviates inflammation and renal injury in mice with lupus nephritis. Allergologia et Immunopathologia. 2025. doi:10.15586/aei.v53i3.1313

BibTeX
@article{Chen2025,
  author = {Chen, Jie and Liu, Lu and Liu, Min and Qin, Mingming and Yan, Suyan and Wu, Chunfeng and Yu, Wenjie},
  title = {Knockdown of TRIM22 regulates the expression of NF-κB/NLRP3 and alleviates inflammation and renal injury in mice with lupus nephritis},
  journal = {Allergologia et Immunopathologia},
  year = {2025},
  doi = {10.15586/aei.v53i3.1313}
}
Kostenlos starten →